Treatments

Research on mesothelioma treatments devoted to your prognosis. Inform yourself on the latest clinical trials and holistic treatments being used now.

Asia | Chemotherapy | International | Symptoms | Treatments

Predicting Kidney Damage from Chemotherapy for Mesothelioma
ByAlex Strauss April 23, 2020

It may be possible to predict which mesothelioma patients are at risk for kidney damage from chemotherapy and take steps…

Read More Predicting Kidney Damage from Chemotherapy for Mesothelioma
Biomarkers | Diagnosis | Immunotherapy | Prognosis | Treatments

Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights
ByAlex Strauss April 20, 2020April 20, 2020

New research conducted by a team of German and Austrian scientists could help make personalized immunotherapy for mesothelioma possible. Mesothelioma…

Read More Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights
Alternatives | Treatments

Tumor Treating Fields for Mesothelioma Still on Track Amidst COVID-19
ByAlex Strauss April 14, 2020

The company that developed tumor treating fields for mesothelioma says it is still making, supporting, and studying the device in…

Read More Tumor Treating Fields for Mesothelioma Still on Track Amidst COVID-19
Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Surgery | Treatments

Radiotherapy Before Mesothelioma Surgery May Not Be Worth the Risk
ByAlex Strauss April 10, 2020

Cancer doctors at Mayo Clinic say they do not plan to start routinely performing radiotherapy before mesothelioma surgery. The idea…

Read More Radiotherapy Before Mesothelioma Surgery May Not Be Worth the Risk
Alternatives | International | New Drugs | Treatments

Curcumin Treatment for Mesothelioma: Research is Encouraging
ByAlex Strauss April 6, 2020

The research on curcumin treatment for mesothelioma looks promising, but more hard science is needed before doctors can incorporate it…

Read More Curcumin Treatment for Mesothelioma: Research is Encouraging
Europe | International | Symptoms | Treatments

Mesothelioma Pain Management with PCC
ByAlex Strauss April 1, 2020

A study out of the UK says more doctors should consider using a minimally invasive surgical technique called PCC in…

Read More Mesothelioma Pain Management with PCC
Multi-Modality Therapy | Surgery | Treatments

Researchers Argue Against Surgery for Mesothelioma
ByAlex Strauss March 26, 2020

A pair of California surgeons say surgery for mesothelioma is rarely worthwhile. They point to what they say are flawed…

Read More Researchers Argue Against Surgery for Mesothelioma
Asia | Immunotherapy | International | New Drugs | Treatments

PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study
ByAlex Strauss March 19, 2020

A study of the PD-L1 inhibitor nivolumab showed “safety and efficacy” in mesothelioma patients who failed with other treatments. Nivolumab…

Read More PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study
New Drugs | New Studies | Research | Treatments

Possible New Drug for Mesothelioma Gets First FDA Approval
ByAlex Strauss March 15, 2020

A possible new drug for mesothelioma has received FDA approval for the treatment of advanced epithelioid sarcoma. Tazemetostat (Tazverik) is…

Read More Possible New Drug for Mesothelioma Gets First FDA Approval
Biomarkers | Diagnosis | Europe | Immunotherapy | International | Treatments

Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed
ByAlex Strauss March 13, 2020

A new report says biomarkers are urgently needed to determine which patients would benefit from immunotherapy for pleural mesothelioma. Researchers…

Read More Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed

1 (888) 378-1331

Treatments

Predicting Kidney Damage from Chemotherapy for Mesothelioma

Personalized Immunotherapy for Mesothelioma: New Research Sheds Lights

Tumor Treating Fields for Mesothelioma Still on Track Amidst COVID-19

Radiotherapy Before Mesothelioma Surgery May Not Be Worth the Risk

Curcumin Treatment for Mesothelioma: Research is Encouraging

Mesothelioma Pain Management with PCC

Researchers Argue Against Surgery for Mesothelioma

PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study

Possible New Drug for Mesothelioma Gets First FDA Approval

Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES